Panuveitis Market Outlook (2026–2030) Driven by Growth Factors

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Panuveitis Market Projected To Reach By 2030?

The panuveitis market size has experienced rapid expansion in recent years. It is projected to grow from $4.46 billion in 2025 to $4.91 billion in 2026, at a compound annual growth rate (CAGR) of 10.1%. This historical growth can be attributed to several factors, including limited awareness of panuveitis, a continued reliance on conventional corticosteroid therapies, low accessibility to ophthalmology specialists, a fragmented treatment infrastructure, and the slow adoption of diagnostic imaging technologies.

The panuveitis market is anticipated to experience substantial expansion over the upcoming years. Its valuation is projected to reach $7.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.8%. This projected increase throughout the forecast timeframe stems from several factors, including developments in biologics and immunomodulatory medications, the rising incidence of autoimmune and infectious eye conditions, the expansion of teleophthalmology services, growing investments in AI-powered diagnostics, and the broadening of hospital and retail pharmacy distribution networks. Key trends expected during this period involve the growing acceptance of targeted biologic treatments, the increased application of teleophthalmology and remote monitoring, the incorporation of AI-driven diagnostic instruments for ocular inflammation, the progression of personalized therapeutic strategies, and the proliferation of specialized ophthalmology facilities.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21244&type=smp

Which Factors Are Influencing The Growth Of The Panuveitis Market?

The increasing occurrence of autoimmune conditions is anticipated to drive expansion in the panuveitis market in the future. These conditions develop when the immune system mistakenly attacks and harms the body’s own healthy cells and tissues. The growing number of autoimmune disease cases can be attributed to a combination of genetic predispositions, environmental factors like pollution and dietary changes, and greater exposure to specific infections and stressors, which can provoke immune system dysregulation. Autoimmune disorders foster progress in panuveitis treatment by stimulating research into immune system modulation, given that numerous instances of panuveitis are linked to autoimmune activity. As an illustration, data from May 2023, provided by the University of Oxford, a UK-based research university, indicates that 10% of the global population is impacted by autoimmune disorders, specifically affecting 13% of women and 7% of males. Consequently, the increasing prevalence of autoimmune conditions is a key factor propelling the expansion of the panuveitis market.

What Are The Different Segment Types In The Panuveitis Market Segment Breakdown?

The panuveitis market covered in this report is segmented –

1) By Type: Infectious Panuveitis, Non-Infectious Panuveitis

2) By Treatment: Pharmacological, Surgical, Phototherapy

3) By Route Of Administration: Oral, Intravitreal, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Infectious Panuveitis: Bacterial Panuveitis, Viral Panuveitis, Fungal Panuveitis, Parasitic Panuveitis

2) By Non-Infectious Panuveitis: Autoimmune-Related Panuveitis, Idiopathic Panuveitis, Drug-Induced Panuveitis

Which Trends Are Influencing Demand In The Panuveitis Market?

Leading companies in the panuveitis market are concentrating on developing innovative products, such as oral TYK2/JAK-1 inhibitors, to achieve a competitive edge. These are small-molecule immunomodulators that function by blocking inflammatory signaling pathways through the inhibition of both TYK2 and JAK-1 kinases, thereby reducing cytokine-driven inflammation within the eye. For example, in April 2024, Roivant Sciences, a US-based biopharma company, announced positive mid-stage clinical data for brepocitinib from its NEPTUNE study concerning non-infectious uveitis, which encompasses panuveitis. The drug demonstrated efficacy in lowering inflammation and macular edema, was well tolerated, and presented no new safety signals. Simultaneously, Alumis, a US biotherapeutic company, initiated patient dosing in June 2023 for its Phase 2 proof-of-concept ESK-001 trial for non-infectious uveitis, including panuveitis; this molecule is highly selective, orally bioavailable, and specifically engineered to minimize off-target effects via allosteric TYK2 inhibition.

Who Are The Well-Known Companies In The Panuveitis Market?

Major companies operating in the panuveitis market are Pfizer Inc., AbbVie, Amgen, Mallinckrodt plc, EyePoint Pharmaceuticals Inc., Clearside Biomedical Inc., pSivida Corp., Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Novartis AG, F Hoffmann-La Roche AG, Regeneron Pharmaceuticals Inc, Sanofi S A, Bausch Health Companies Inc, Johnson & Johnson, UCB SA, Aldeyra Therapeutics Inc, Kiora Pharmaceuticals Inc, Lux Biosciences Inc, Aciont Inc, Sirion Therapeutics Inc, EyeGate Pharmaceuticals Inc, Oculis Pharma AG, Alcon Inc, Sun Pharmaceutical Industries Ltd, Aerie Pharmaceuticals Inc.

Get The Full Panuveitis Market Report:

https://www.thebusinessresearchcompany.com/report/panuveitis-global-market-report

Which Region Is The Leading Market For The Panuveitis Market?

North America was the largest region in the panuveitis market in 2025. The regions covered in the panuveitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Panuveitis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/panuveitis-global-market-report

Browse Through More Reports Similar to the Global Panuveitis Market 2026, By The Business Research Company

Generalized Anxiety Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Major Depressive Disorder Market Report

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

Mental Health Market Report

https://www.thebusinessresearchcompany.com/report/mental-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795